DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
{{output}}
Direct-acting antiviral (DAA) therapy is associated with a significant reduction in hepatocellular carcinoma (HCC) incidence among patients with cirrhosis, but data are conflicting about the risk of recurrence following DAA therapy. DAA-PASS was a prospective,... ...
